Position in JNJ
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$19,654,442
+$3,214,334 QoQ
Shares Held
80,406
+1.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.67%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $104,513,791 across 18 Drug Manufacturers - General names. JNJ ranks #3 (18.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,405 | $27,965,606 | |
| 2 | ABBV |
AbbVie Inc.
|
103,875 | $22,591,773 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
80,406 | $19,654,442 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
75,984 | $10,589,890 | |
| 5 | MRK |
Merck & Co., Inc.
|
56,169 | $6,756,569 | |
| 6 | PFE |
Pfizer Inc
|
129,199 | $3,627,907 | |
| 7 | AMGN |
Amgen Inc
|
10,183 | $3,582,888 | |
| 8 | NVS |
Novartis AG
|
16,366 | $2,499,906 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,654,442 | 80,406 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $16,440,108 | 79,440 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $13,993,091 | 75,467 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $11,128,906 | 72,857 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $12,636,178 | 76,195 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $10,480,756 | 72,471 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $12,630,308 | 77,936 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $10,536,235 | 72,087 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $12,584,172 | 79,551 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $10,674,620 | 68,104 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $11,661,002 | 74,870 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $12,016,752 | 72,600 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $10,500,010 | 67,742 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $10,350,100 | 58,591 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $9,183,772 | 56,218 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $9,981,564 | 56,231 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $9,199,300 | 51,906 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $8,171,500 | 47,767 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $7,973,578 | 49,372 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $7,495,340 | 45,498 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $6,505,466 | 39,583 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $5,449,912 | 34,629 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $5,475,508 | 36,778 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $5,122,166 | 36,423 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $4,820,601 | 36,762 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||